|
HRC has Two Winner's in Ferrings National "Miracle Babies" Contest" See Details.
HRC Fertility’s Dr. Potter Discusses Infertility Treatment Options on Sirius Radio
Hear the Broadcast
HRC Fertility’s Daniel Potter, MD interviewed for NPR Series Examining Use, Ethics Of PGD For Embryonic Disease Screening and Sex Selection
NPR’s “All Things Considered” recently rebroadcast a segment including three reports on the use of Preimplantation Genetic Diagnosis (PGD) to screen embryos. Some doctors analyze an embryo's DNA so parents can choose to have a male or female placed in the womb. Last year, a survey found that 1 of every 11 Pre-Implantation Genetic Diagnosis treatment was for sex-selection alone. The study by Johns Hopkins University also found that 42 percent of clinics offering PGD offer it for sex selection. HRC Fertility’s Daniel Potter, MD was interviewed regarding his views on PGD for sex selection.
Dr. Potter's Article
|
